Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D02CPV
|
||||
| Former ID |
DNC000087
|
||||
| Drug Name |
5-Hydroxyeicosatetraenoic acid
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [1], [2] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C20H32O3
|
||||
| Canonical SMILES |
CCCCCC=CCC=CCC=CC=CC(CCCC(=O)O)O
|
||||
| InChI |
1S/C20H32O3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-16-19(21)17-15-18-20(22)23/h6-7,9-10,12-14,16,19,21H,2-5,8,11,15,17-18H2,1H3,(H,22,23)/b7-6-,10-9-,13-12-,16-14+/t19-/m1/s1
|
||||
| InChIKey |
KGIJOOYOSFUGPC-JGKLHWIESA-N
|
||||
| CAS Number |
CAS 72255-35-7
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID |
7367, 4266109, 8616380, 14717639, 15469964, 26754739, 26754740, 39289780, 47290863, 47364900, 47364901, 49964846, 50110766, 53788764, 57357855, 77570786, 92309859, 99300773, 99302291, 103419145, 103936995, 104046382, 113853892, 126529724, 134339618, 135111503, 135651416, 137008431, 142970226, 164789588, 179205486, 184568140, 227683983, 249492905, 252371371, 252455583, 252465535
|
||||
| Target and Pathway | |||||
| Target(s) | Arachidonate 5-lipoxygenase | Target Info | Inhibitor | [1], [2] | |
| BioCyc Pathway | Aspirin-triggered lipoxin biosynthesis | ||||
| Resolvin D biosynthesis | |||||
| Leukotriene biosynthesis | |||||
| Lipoxin biosynthesis | |||||
| Aspirin triggered resolvin D biosynthesis | |||||
| Aspirin triggered resolvin E biosynthesis | |||||
| KEGG Pathway | Arachidonic acid metabolism | ||||
| Metabolic pathways | |||||
| Serotonergic synapse | |||||
| Ovarian steroidogenesis | |||||
| Toxoplasmosis | |||||
| NetPath Pathway | IL4 Signaling Pathway | ||||
| PathWhiz Pathway | Arachidonic Acid Metabolism | ||||
| WikiPathways | Vitamin D Receptor Pathway | ||||
| Arachidonic acid metabolism | |||||
| Eicosanoid Synthesis | |||||
| Selenium Micronutrient Network | |||||
| References | |||||
| REF 1 | Preview of potential therapeutic applications of leukotriene B4 inhibitors in dermatology. Skin Pharmacol Appl Skin Physiol. 2000 Sep-Oct;13(5):235-45. | ||||
| REF 2 | Cellular oxygenation of 12-hydroxyeicosatetraenoic acid and 15-hydroxyeicosatetraenoic acid by 5-lipoxygenase is stimulated by 5-lipoxygenase-activating protein. J Biol Chem. 1998 Dec 4;273(49):32842-7. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.